Eggleston, M., Eggleston, K., Thabrew, H., Hennig, S., & Frampton, C. (2021). Order out of chaos? Autism spectrum disorder coordinators' impact on service delivery in New Zealand. Australasian Psychiatry. Advance online publication. doi: 10.1177/10398562211009249

Journal - Research Article

Moot, W., Crowe, M., Inder, M., Eggleston, K., Frampton, C., & Porter, R. (2021). Functional and mood outcomes in bipolar disorder patients with and without substance use disorders undergoing psychotherapy. Frontiers in Psychiatry, 12, 661458. doi: 10.3389/fpsyt.2021.661458

Journal - Research Article

Sukhapure, M., Eggleston, K., Douglas, K., Fenton, A., Frampton, C., & Porter, R. J. (2021). Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome. Archives of Women's Mental Health. Advance online publication. doi: 10.1007/s00737-021-01158-9

Journal - Research Article

Crowe, M., Inder, M., Porter, R., Wells, H., Jordan, J., Lacey, C., Eggleston, K., & Douglas, K. (2020). Patients' perceptions of functional improvement in psychotherapy for mood disorders. American Journal of Psychotherapy. Advance online publication. doi: 10.1176/appi.psychotherapy.202020200017

Journal - Research Article

Eggleston, M. J. F., Thabrew, H., Frampton, C. M. A., Eggleston, K. H. F., & Hennig, S. C. (2019). Obtaining an autism spectrum disorder diagnosis and supports: New Zealand parents’ experiences. Research in Autism Spectrum Disorders, 62, 18-25. doi: 10.1016/j.rasd.2019.02.004

Journal - Research Article

Reeves, S., Eggleston, K., Cort, E., McLachlan, E., Brownings, S., Nair, A., … Howard, R. (2018). Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP). International Journal of Geriatric Psychiatry, 33(2), 396-404. doi: 10.1002/gps.4758

Journal - Research Article

Crowe, M., Eggleston, K., Douglas, K., & Porter, R. J. (2021). Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. Bipolar Disorders, 23(2), 141-151. doi: 10.1111/bdi.12971

Journal - Research Other

Eggleston, K., & Porter, R. (2021). Cognitive screening in electroconvulsive therapy: Don't forget subjective cognition. Australian & New Zealand Journal of Psychiatry. Advance online publication. doi: 10.1177/0004867421998784

Journal - Research Other

Eggleston, K., & Porter, R. (2021). Lymphadenopathy: A rare but important side effect of lamotrigine. Australian & New Zealand Journal of Psychiatry. Advance online publication. doi: 10.1177/00048674211011260

Journal - Research Other

Crowe, M., Porter, R., Eggleston, K., & Douglas, K. (2020). Addressing cognitive impairment in mood disorders: A role for the mental health nurse. Journal of Psychiatric & Mental Health Nursing, 27, 319-320. doi: 10.1111/jpm.12613

Journal - Research Other

Eggleston, K., & Myles, H. (2020). Advice to potential academics from researchers who have seen 'et al.'. Australian & New Zealand Journal of Psychiatry. Advance online publication. doi: 10.1177/0004867420972757

Journal - Research Other

Eggleston, K., & Porter, R. (2020). Subjective memory impairment after electroconvulsive therapy: Potentially modifiable? BJPsych Open, 6(3), e38. doi: 10.1192/bjo.2020.20

Journal - Research Other

Porter, R. J., & Eggleston, K. (2020). Neurocognitive effects of electroconvulsive therapy: What do patients and clinicians need to know? American Journal of Geriatric Psychiatry, 28(3), 317-319. doi: 10.1016/j.jagp.2019.10.017

Journal - Research Other